- Article metrics
- Last updated: Tue, 20 May 2025 15:35:58 Z
Dapagliflozin improves podocytes injury in diabetic nephropathy via regulating cholesterol balance through KLF5 targeting the ABCA1 signalling pathway
Access & Citations
-
- 1377
- Article Accesses
-
- Data not available
- Web of Science
-
- Data not available
- CrossRef
Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.